Sawtooth Solutions, LLC Oncorus, Inc. Transaction History

Sawtooth Solutions, LLC

  • $3.64 Billion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 12, 2022
SELL
$0.85 - $1.65 $34,499 - $66,970
-40,588 Reduced 52.48%
36,748 $31,000
Q2 2022

Jul 19, 2022
BUY
$1.04 - $1.86 $15,010 - $26,845
14,433 Added 22.94%
77,336 $97,000
Q1 2022

May 20, 2022
BUY
$1.44 - $5.62 $90,580 - $353,514
62,903 New
62,903 $112,000

About Oncorus, Inc.

ONCR Quotes by TradingView
  • Ticker ONCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,973,100
  • Description
  • Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...
More about ONCR
Track This Portfolio

Track Sawtooth Solutions, LLC Portfolio

Follow Sawtooth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawtooth Solutions, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email